Cargando…
Ingenol mebutate: A novel topical drug for actinic keratosis
The global incidence of non-melanoma skin cancer is rising. Significant morbidity leading to unacceptable cosmetic outcomes and/or functional impairment is a major concern. Search for non-surgical, non-invasive and tissue-sparing treatment modalities has led to development of new therapeutic agents....
Autores principales: | Aditya, Suruchi, Gupta, Sanjeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752492/ https://www.ncbi.nlm.nih.gov/pubmed/23984250 http://dx.doi.org/10.4103/2229-5178.115538 |
Ejemplares similares
-
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012) -
Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017) -
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
por: Campione, Elena, et al.
Publicado: (2016) -
Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017) -
Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
por: Lesiak, Aleksandra, et al.
Publicado: (2019)